ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

11 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

08 Mar 2024 10:29:15 By NetDania Notify

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

07 Mar 2024 09:45:14 By NetDania Notify

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

06 Mar 2024 09:45:03 By NetDania Notify

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

05 Mar 2024 10:22:45 By NetDania Notify

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

05 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

04 Mar 2024 11:15:21 By NetDania Notify

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

29 Feb 2024 10:08:19 By NetDania Notify

ADMA Biologics Announces CFO Transition

28 Feb 2024 16:10:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

28 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

27 Feb 2024 09:45:15 By NetDania Notify

ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

21 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK

12 Feb 2024 14:16:30 By NetDania Notify

ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update

08 Jan 2024 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management

18 Dec 2023 16:05:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older

12 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD

16 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update

08 Nov 2023 16:05:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023

01 Nov 2023 07:00:00 By Nasdaq GlobeNewswire